Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
26.96
Dollar change
-0.68
Percentage change
-2.46
%
IndexRUT P/E- EPS (ttm)-9.44 Insider Own18.39% Shs Outstand27.50M Perf Week7.75%
Market Cap741.31M Forward P/E- EPS next Y-2.70 Insider Trans0.69% Shs Float22.44M Perf Month17.78%
Income-72.31M PEG- EPS next Q-0.46 Inst Own71.68% Short Float8.96% Perf Quarter12.24%
Sales0.00M P/S- EPS this Y63.51% Inst Trans73.98% Short Ratio12.72 Perf Half Y64.29%
Book/sh7.46 P/B3.61 EPS next Y9.62% ROA-29.53% Short Interest2.01M Perf Year128.78%
Cash/sh7.14 P/C3.78 EPS next 5Y33.00% ROE-34.67% 52W Range9.51 - 31.00 Perf YTD117.42%
Dividend Est.- P/FCF- EPS past 5Y-483.52% ROI-37.28% 52W High-13.03% Beta0.49
Dividend TTM- Quick Ratio23.23 Sales past 5Y0.00% Gross Margin- 52W Low183.40% ATR (14)1.90
Dividend Ex-DateMar 15, 2024 Current Ratio23.23 EPS Y/Y TTM41.13% Oper. Margin0.00% RSI (14)55.86 Volatility6.87% 8.09%
Employees6 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.14 Target Price35.57
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q94.13% Payout- Rel Volume0.97 Prev Close27.64
Sales Surprise- EPS Surprise16.44% Sales Q/Q- EarningsNov 06 BMO Avg Volume157.94K Price26.96
SMA203.55% SMA5012.81% SMA20039.88% Trades Volume153,382 Change-2.46%
Date Action Analyst Rating Change Price Target Change
Sep-27-24Initiated Raymond James Outperform $37
Aug-12-24Initiated H.C. Wainwright Buy $38
Apr-15-24Initiated William Blair Outperform
Apr-15-24Initiated Leerink Partners Outperform $32
Apr-10-24Initiated Citigroup Buy $34
Mar-27-24Initiated Piper Sandler Overweight $28
Feb-23-23Downgrade Cowen Outperform → Market Perform
Feb-23-23Downgrade Cantor Fitzgerald Overweight → Neutral $3
Feb-23-23Downgrade BofA Securities Neutral → Underperform $3 → $2
Jan-25-23Downgrade BTIG Research Buy → Neutral
Oct-30-24 08:00AM
Oct-27-24 09:00PM
Oct-22-24 08:10AM
Oct-21-24 08:00AM
Sep-30-24 08:00AM
04:01PM Loading…
Aug-27-24 04:01PM
Aug-14-24 04:05PM
Aug-12-24 08:00AM
Aug-07-24 04:01PM
Jul-15-24 08:00AM
Jun-10-24 08:00AM
May-30-24 08:00AM
May-12-24 09:03AM
May-08-24 04:01PM
May-01-24 04:01PM
07:00AM Loading…
Apr-03-24 07:00AM
Apr-02-24 04:01PM
Mar-21-24 04:30PM
10:09AM
Mar-08-24 05:00PM
Mar-01-24 10:48AM
Feb-02-24 11:58AM
Jan-27-24 12:07PM
Nov-16-23 12:00PM
Nov-15-23 07:00AM
Jun-23-23 07:00AM
May-15-23 07:44AM
May-10-23 10:18AM
Apr-26-23 02:10PM
Mar-29-23 04:20PM
10:12AM Loading…
Mar-25-23 10:12AM
Mar-20-23 04:05PM
Feb-23-23 05:36PM
Feb-22-23 04:05PM
Jan-10-23 09:35AM
Jan-06-23 05:54PM
09:07AM
Jan-05-23 05:57PM
04:05PM
Dec-11-22 10:00AM
Nov-21-22 08:00AM
Nov-17-22 09:45AM
Nov-09-22 04:05PM
Nov-03-22 09:05AM
Oct-16-22 08:33AM
Oct-11-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 05:47PM
Aug-11-22 04:05PM
08:16AM
Jun-17-22 02:26PM
Jun-01-22 08:00AM
May-29-22 02:15PM
May-16-22 06:00AM
May-12-22 04:05PM
May-09-22 08:13AM
May-04-22 08:00AM
May-03-22 08:00AM
May-02-22 04:38PM
Mar-28-22 08:00AM
Mar-23-22 12:28PM
08:00AM
Mar-21-22 08:25AM
Mar-03-22 08:00AM
Mar-02-22 08:00AM
Feb-08-22 10:20AM
Jan-27-22 08:00AM
Jan-26-22 06:30PM
Dec-11-21 09:00AM
Dec-07-21 08:00AM
Nov-17-21 08:00AM
Nov-10-21 04:05PM
Nov-04-21 09:13AM
Oct-21-21 08:00AM
Oct-18-21 11:00AM
04:37AM
Oct-12-21 01:00PM
Oct-05-21 08:00AM
Sep-25-21 10:12AM
Aug-30-21 08:00AM
Aug-12-21 04:05PM
Jun-30-21 05:15PM
Jun-24-21 09:08PM
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schimmelpennink Evert B.President, CEO and SecretaryJul 22 '24Option Exercise1.0445,00046,80045,000Jul 23 08:16 PM
Chevallard Daniel R.Chief Financial OfficerMay 14 '24Buy15.683,18849,9883,188May 15 04:13 PM
MCCOLLUM JAMES WDirectorMay 13 '24Buy15.9931,332501,093525,565May 14 05:29 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 21 '24Buy15.03998,00915,000,0753,319,339Mar 25 08:48 PM